For biologic-naive adults with moderate to excessive Crohn’s illness, remedy with adalimumab or ustekinumab ends in identical outcomes, in line with outcomes of the high-to-head…
For biologic-naive adults with moderate to excessive Crohn’s illness, remedy with adalimumab or ustekinumab ends in identical outcomes, in line with outcomes of the high-to-head…